Page 70 - GTM-4-2
P. 70

Global Translational Medicine                                           Glucosidase and metabolic profiles



            resistance, computed as homeostatic model assessment   observation period was greater in the control compared
            (HOMA), was determined as described by Wallace et al. 30   to the MIG group. Specifically, these data indicate that
            Glycated hemoglobin (hemoglobin A1C [HbA1c], gamma-  the net energy intake of control rats was approximately
            hydroxybutyric acid) and lipid analysis were also performed.   13% greater overall than that of the MIG-fed rats over the
            Plasma  triglycerides,  cholesterol,  and  the  α-lipoprotein   8-week period (Figure 2, left grouped bars). Additionally,
            (LDL and β-lipoprotein high-density lipoprotein [HDL])   there was a modest improvement in feed efficiency for the
            fractions  were  determined  spectrophotometrically  MIG regimen (Figure 2, right grouped bars). The effects
            (Beckman AU480, United States of America) following
            affinity chromatographic separation, according to the   0.3
            procedure of Bentzen  et al., and triglycerides were   0.25                       p<0.05 (trend)
            measured by the enzymatic method of Bucolo and David,
            with all reagents acquired from Fischer Scientific (United   0.2  p<0.05
            States of America) and prepared on-site. 31,32  Measures of   Food intake (kg)/7 weeks  0.15
            glycolytic enzyme activity, including glucokinase, malic   0.1
            enzyme, and glucose-6-phosphate dehydrogenase, were   0.05
            determined spectrophotometrically and expressed as      0
            micro moles of product produced per minute per mg of          Kg  Food intake        Fer
            protein per liver in a sucrose-ethylenediaminetetraacetic               Control  Miglitol
            acid-phosphate buffered liver homogenate, as described   Figure 2. Effect of α-glucosidase inhibitor miglitol on net energy intake
            by Freeland.  Tissue protein content was determined as   and feed efficiency ratio. Data are expressed as mean ± 1 standard error
                      33
            described  by Lowry  et al. 34,35   Data  were  analyzed using   of the mean (n=8 rats/group).  p<0.05 through Student’s  t-test;  p<0.05
                                                               (trend) through Page’s L test for trend analysis.
            standard statistical procedures, including the application   Abbreviation: Fer: Feed efficiency ratio.
            of  Page’s  L  test  for  trend  analysis  with  corrections  for
            covariates, where statistical significance through the
            t-test was suggestive but not confirmatory. 36,37  The study   A  180  p<0.05  B  940
            was approved by the Institutional Animal Care and Use   160                 920        p<0.05
            Committee, University of Science Arts and Technology   140                  900
                                                                  120
                                                                                        880
            (approval number: 2016/009).                         Glucose (mg/dl)  100   860
                                                                   80
                                                                                        840
            3. Results                                             60                  Insulin (μU/ml)  820
                                                                   40                   800
            Initial and final body weights, net weight gain, and   20                   780
            dietary energy intake of rats over the 8-week observation   0  Glucose, mg/dl  760  Insulin, µU/ml
            period are depicted in Figures 1-6. Daily energy intake is   Control  Miglitol    Control  Miglitol
            depicted in  Figure  1,  which  shows that  control  animals   Figure  3. Effect of miglitol on fasting glucose (A) and insulin (B) at
            consumed more energy per day from week 1 to week 8. The   the end of the study. Data are presented as mean ± 1 standard error of
            cumulative energy intake over the 8 weeks is presented in   the mean (n=6 rats/group). p<0.05 (Student’s t-test). This resulted in a
            Figure 2, confirming that the net energy intake during the   modest 5% decrease in the mean homeostatic model assessment score
                                                               from 2.6 ± 0.1 (control) to 2.4 ± 0.1 (miglitol) (p > 0.05).
              120
                                                                  20
              100
                                                                            p<0.05            p<0.05
               80                                                 15
             kcal/rat/day  60  p<0.05 (Control vs Miglitol from week one)  Percent (%)  10
               40
               20                                                 5
                                                                  0
               0                                                            AUC glc             GHB, %
                 Week 0Week IWeek 2Week 3Week 4Week 5Week 6Week 7Week 8            Control  Miglitol
                              Control  Miglitol
                                                               Figure 4. Effect of miglitol on glycemic parameters at 15 weeks of age.
            Figure 1. Effect of miglitol on weekly food intake in obese type 2 diabetes   Data are expressed as mean ± 1 standard error of the mean (n=6 – 8 rats/
            mellitus rats. Data are presented as mean ± 1 standard error of the mean   group). p<0.05 as determined by Student’s t-test.
            (n=6–8 rats/group). p<0.05 for control versus miglitol from week 1 to   Abbreviations: AUC glc: Area under the glucose tolerance curve; GHB:
            week 8. (Students t-test, individual comparisons: Control vs. miglitol).  Glycated hemoglobin.


            Volume 4 Issue 2 (2025)                         62                              doi: 10.36922/gtm.6501
   65   66   67   68   69   70   71   72   73   74   75